Close
Digital Health & Ai Innovation summit 2026
APE 2026

Industry Updates

Philips launches new handheld blood test for rapid point-of-care diagnosis of heart attack

Launch in selected countries in Europe follows CE marking for Philips Minicare I-20 system for cardiac troponin testingHandheld Minicare I-20 system for use in emergency...

Medtronic and Qualcomm Collaborate to Aim to Improve Care and Health Outcomes for People with Type 2

Joint Development of Future Generation Continuous Glucose Monitoring (CGM) Systems Aims to Provide Actionable Insights to Help Deliver Integrated Diabetes CareMedtronic plc and Qualcomm Incorporated...

The Nederlandse Obesitas Kliniek and Medtronic Plc Join Forces in the Battle Against Morbid Obesity

The Nederlandse Obesitas Kliniek  and Medtronic plc a global leader in medical technology, services and solutions, today announced that Medtronic has signed an agreement to...

Point-of-care ultrasound indispensable for elite sport in Wales

Point-of-care ultrasound is an essential tool for Dr Mark Ridgewell, an early pioneer for sports and exercise medicine (SEM) and, for the past 13 years,...

3M Announces Interactive Compendium on the Science and Clinical Benefits of Patient Warming

3M, a world leader in infection prevention, announced the publication of a robust research compendium highlighting the safety and effectiveness of the 3M™ Bair Hugger™...

European Medicines Agency accepted Sandozs biosimilar rituximab regulatory submission

Sandoz advances biosimilar portfolio with sixth major biosimilar file acceptance in less than one yearSandoz is seeking approval for all indications included in the reference...

FDA Expands Indication of INVOKAMET (canagliflozin/metformin HCl) to Include First-Line Treatment of

Janssen Pharmaceuticals, Inc. announced the U.S. FDA has approved INVOKAMET, a fixed-dose combination therapy of INVOKANA® (canagliflozin) and metformin hydrochloride, for first-line treatment of adults...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »